Scrip    Clinica    Scrip Regulatory Affairs    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
Acetylon raises $27M to test selective HDAC inhibitor in clinic for cancer
06 July 2011
Nancy Faigen

nancy.faigen@informausa.com





Please Login to read the full article.
 
Not a subscriber? Subscribe to Scrip Request a FREE Trial
RELATED CONTENT
NEWS Scrip News Other Informa News
COMMENT Scrip Comment Other Informa Comment
FEATURES Other Informa Features
EVENTS
22 May 2012
Le Plaza Hotel, Brussels, Belgium
22 May 2012
Diplomat Hotel, Prague, Czech Republic
22 May 2012
Business Design Centre, London
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm